The estimated Net Worth of Kevin Patrick Danahy is at least $615 Tisíc dollars as of 16 November 2023. Kevin Danahy owns over 5,393 units of Pulse Biosciences Inc stock worth over $615,103 and over the last 3 years Kevin sold PLSE stock worth over $0.
Kevin has made over 2 trades of the Pulse Biosciences Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently Kevin bought 5,393 units of PLSE stock worth $35,162 on 16 November 2023.
The largest trade Kevin's ever made was buying 6,500 units of Pulse Biosciences Inc stock on 30 September 2022 worth over $14,950. On average, Kevin trades about 1,321 units every 46 days since 2022. As of 16 November 2023 Kevin still owns at least 35,887 units of Pulse Biosciences Inc stock.
You can see the complete history of Kevin Danahy stock trades at the bottom of the page.
Kevin's mailing address filed with the SEC is C/O PULSE BIOSCIENCES, INC., 3957 POINT EDEN WAY, HAYWARD, CA, 94545.
Over the last 8 years, insiders at Pulse Biosciences Inc have traded over $0 worth of Pulse Biosciences Inc stock and bought 18,070,761 units worth $194,618,110 . The most active insiders traders include Robert W Duggan, Mahkam Zanganeh a Manmeet Singh Soni. On average, Pulse Biosciences Inc executives and independent directors trade stock every 52 days with the average trade being worth of $6,179,107. The most recent stock trade was executed by Burke Thomas Barrett on 20 May 2024, trading 10,000 units of PLSE stock currently worth $85,600.
pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and
Pulse Biosciences Inc executives and other stock owners filed with the SEC include: